Phase
Condition
Brain Tumor
Hiv
Meningitis
Treatment
Community-acquired CNS infections
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Definitions of central nervous system infections:
For all cases with unproven aetiologies no alternative diagnosis than CNS infection is thought more likely after completed multidisciplinary diagnostic work-up.
Viral meningitis inclusion criteria
- All patients have to have a clinical presentation consistent with non-bacterial meningitis (e.g. headache, neck stiffness, photo- or phonophobia, fever)
and
Cerebrospinal fluid leukocytes>10 cells/ml
Patients with viral meningitis with undetermined pathogen have to have:
- CSF leukocytes> 10/mL and no other more probable diagnosis assessed by the local investigator.
In case of doubt, patients are discussed with the DASGIB secretary and chair or at meetings.
Bacterial meningitis inclusion criteria - All patients have to have a clinical presentation consistent with bacterial meningitis (e.g. headache, neck stiffness, fever, altered mental status)
and
Proven bacterial aetiology (CSF or blood culture/DNA based technology or antigen tests)
Patients with bacterial meningitis in whom the bacteria cannot not be cultured or identified by DNA-based technologies have to have:
- CSF leukocytes> 10/mL and no other more probable diagnosis assessed by the local investigator.
In case of doubt, patients are discussed with the DASGIB secretary and chair or at meetings.
Encephalitis inclusion criteria - All patients have to have a clinical presentation consistent with encephalitis (e.g. headache, fever, focal neurological deficit, altered mental status >24 hours) as defined by the International Encephalitis Consortium (Venkatesan A et al., Clin Infect Dis 2013; doi:10.1093/cid/cit458.).
Encephalitis exclusion criteria
- We exclude cases of proven or suspected autoimmune encephalitis.
Primary brain abscess inclusion criteria
- All patient have a clinical presentation consistent with brain abscess (e.g. headache, focal neurological deficit, mass lesion on cranial imaging)
and
- Proven microbiological aetiology by culture/DNA-based technology from pus from brain abscess or blood or CSF
or
- Aspiration of pus from the brain abscess
or
- Response to antimicrobial treatment
or
- Tumour ruled out
or
- Tumour thought less probable than abscess on MRI using diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) sequences.
Lyme neuroborreliosis inclusion criteria
- A clinical presentation consistent with neuroborreliosis (e.g. radiculopathy)
and
- CSF pleocytosis>10 leukocytes/mL
and
- Positive intrathecal B.burgdorferi antibody production index.
Neurosyphilis inclusion criteria - A clinical presentation consistent with neurosyphilis (e.g. 'encephalitis-like symptoms', dementia, ocular or otogenic syphilis)
and either
- Positive syphilis serology in serum combined with CSF leukocytes>10/mL
or
- CSF syphilis antibodies.
Study Design
Study Description
Connect with a study center
Department of Infectious Diseases, Aalborg University Hospital
Aalborg, 9000
DenmarkActive - Recruiting
Department of Infectious Diseases, Aarhus University Hospital Skejby
Aarhus, 8000
DenmarkActive - Recruiting
Department of Infectious Diseases, Rigshospitalet
Copenhagen, 2100
DenmarkActive - Recruiting
Herlev-Gentofte Hospital
Copenhagen,
DenmarkActive - Recruiting
Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital Hillerød
Hillerød, 3400
DenmarkActive - Recruiting
Department of Infectious Diseases, Hvidovre Hospital
Hvidovre, 2650
DenmarkActive - Recruiting
Department of Infectious Diseases, Odense University Hospital
Odense, 5100
DenmarkActive - Recruiting
Department of Pulmonary and Infectious Diseases, Sjællands University Hospital Roskilde
Roskilde, 4000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.